Case ReportPubMed ID: 18844676·2008

Case Report: TB-500 in Diabetic Foot Ulcer with Delayed Healing

Shen JG, Du AL, Levine B, et al.

International Journal of Dermatology, 2008 · n = 1

Key finding

12-week old diabetic ulcer (4.5cm x 3.2cm) achieved 100% closure within 8 weeks with weekly TB-500 injections.

Summary

Single patient case report of TB-500 treatment for chronic diabetic foot ulcer refractory to standard care.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

TB-500L3

A naturally occurring peptide central to cell migration and tissue repair. Phase 2 human wound healing trials showed accelerated healing; also studied for cardiac and corneal repair.

More research on TB-500

The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients

Annals of the New York Academy of Sciences · 2012 · Human Pilot

TB-500 Improves Neurological Recovery After Traumatic Brain Injury

Journal of Neurotrauma · 2011 · Animal Study

Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

Expert Opinion on Biological Therapy · 2010 · Review

Thymosin Beta-4 Regulates Inflammation and Promotes Macrophage M2 Polarization

Journal of Molecular Medicine · 2010 · In Vitro

Thymosin beta4 and cardiac repair

Annals of the New York Academy of Sciences · 2009 · Animal Study